Get the tools used by (smart)2 investors.

Net Income to Company for Teva Pharmaceutical Industries Limited

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

TEVA: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internatio...

7.85 CHF
Price
CHF
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Teva Pharmaceutical Industries Limited's Net Income to Company:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-15 B-10 B-5 B0 K

Performance Summary
  • Teva Pharmaceutical Industries's latest twelve months net income to company is -1.778 billion
  • Teva Pharmaceutical Industries's net income to company for fiscal years ending December 2020 to 2024 averaged -1.564 billion.
  • Teva Pharmaceutical Industries's operated at median net income to company of -1.778 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Teva Pharmaceutical Industries's net income to company peaked in December 2021 at 416 million.
  • Teva Pharmaceutical Industries's net income to company hit its 5-year low in December 2020 of -3.629 billion.
  • Teva Pharmaceutical Industries's net income to company decreased in 2020 (-3.629 billion, +274.7%), 2022 (-2.311 billion, -655.4%), and 2024 (-1.778 billion, +243.6%) and increased in 2021 (416 million, -111.5%) and 2023 (-517.3 million, -77.6%).

How does Teva Pharmaceutical Industries's Net Income to Company benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Teva Pharmaceutical Industries Limited because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Net Income to Company

Hide this widget
ni_company
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Income to Company in the financials category include:

  • Accounts Receivable, Net - The total amount of collectibles for a company net of receivables that are deemed to be uncollectible.
  • Deferred Tax Assets, Long-term - A non-current asset created by a difference between accounting for income tax purposes and financial reporting purposes.
  • Long-Term Debt Issued - This item represents cash inflow on issuance of any debt that is long-term in nature.
  • Beginning Cash (CF) - This item represents cash and cash equivalents as at the beginning of the period.
View Full List

Search for metric or datapoint

Net Income to Company

This item represents the net income available to all stakeholders of the company and is presented as total income or loss before discontinued operatio...

Definition of Net Income to Company

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-303.9 M96.146 M496.1 M1.185 B04008001,200

The chart above depicts the distribution of net income to company for companies operating in the Healthcare sector in the Developed economic region. Over 2,500 companies were considered in this analysis, and 2,406 had meaningful values. The average net income to company of companies in the sector is -87.907 K with a standard deviation of 134.2 M.

Teva Pharmaceutical Industries Limited's Net Income to Company of -1.778 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Net Income to Company In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,506
Included Constituents2,406
Min-328.6 M
Max1.175 B
Median-4.597 M
Mean-87.907 K
Standard Deviation134.2 M

You can find companies with similar net income to company using this stock screener.

All rights reserved. Terms Of Use